Preparation of itraconazole amorphous solid dispersion and preliminary evaluation in vitro
10.11665/j.issn.1000-5048.20180208
- VernacularTitle:伊曲康唑无定型固体分散体的制备及体外评价
- Author:
Ziyue HONG
1
;
Shenyi SHI
;
Yushen GUO
;
Jianping LIU
Author Information
1. 中国药科大学药剂系
- Publication Type:Journal Article
- Keywords:
hot-melt extrusion;
amorphous solid dispersion;
itraconazole;
dissolution;
Soluplus
- From:
Journal of China Pharmaceutical University
2018;49(2):187-194
- CountryChina
- Language:Chinese
-
Abstract:
Aimed at developing new formulation, amorphous solid dispersion of itraconazole was prepared via hot-melt extrusion technology and compared with sporanox for improving its dissolution. According to the solubility parameter and glass transition temperature, Soluplus, Kollidon VA64, HPMCAS and Eudragit EPO were used as carriers. After screening the carriers by modulated temperature-differential scanning calorimetry(MT-DSC), the amorphous solid dispersion was prepared successfully and characterized by MT-DSC, polarized light microscope(PLM), X-ray powder diffraction(XRPD)and Fourier Transform InfraRed(FT-IR). Results suggested that the amorphous form of ITZ solid dispersion and whether the interaction between polymer and ITZ was appeared. Using 30% and 50% drug loading, solid dispersion were tested by in vitro dissolution and kinetic solubility tests. When using Soluplus(3 ∶7)as carrier and extrusion temperature of 170 ℃, dissolution rate of itraconazole was improved significantly compared to Sporanox. In 40 ℃, 75% RH condition, itraconazole in the solid dispersion was amorphous for 30 d with no crystal observed. MT-DSC indicated the molecular level miscibility between Soluplus and amorphous itraconazole was probably the main cause of solubilization. The result from this research help understanding the solublization of amorphous itraconazole and future formulation development.
